RELAFEN TABLETS 750MG
RELAFEN TABLETS 750MG
Discontinued
DIN Number
02083558
Drug Class
Human
Market Date
Jan 29, 1998
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02083558
AIG Number0122821002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01AX01 NABUMETONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
NABUMETONEActive
Strength: 750 MG
Monograph: NABUMETONE